Topics
 
- Antimicrobial Stewardship
- Biofilm Formation and Antibiotic Therapy
- Blood-Stream Infections and Infective Endocarditis
- Diagnostics in Infectious Diseases
- Fungal Infections
- Infections in Surgery
- Infections in the ICU
- New Antimicrobial Agents
-

New Trends in Vaccination

- Pathogenesis and Treatment of Sexually Transmitted Infections
-Respiratory Tract Infections
-Urinary Tract Infections
-Viral Infections: New Trends in HIV, Hepatitis B/C and Influenza
Keynote Lectures
 
As per September 2010
 
Hans Burkardt Switzerland, Rotkreuz
MRSA: The burden in hospital acquired infections and strategies against
Giuseppe Cornaglia Italy, Verona
1911-2010: Gustav Mahler from life to myth (Opening Lecture)
Harald Fischer Austria, Vienna
Vaccination - News
Stefanos Geroulanos Greece, Athens
How we managed to keep our ICU MRS A-, Pseudomonas-, Klebsiella-, VRE- and "Acinetobacter-", free
Wolfgang Graninger Austria, Vienna
New Antimicrobials - State of the Art
Andreas H. Groll Germany, Münster
Management & combination therapy of invasive fungal infections
Yesim Gurol Yeditepe, Turkey
New diagnostics for active and latent tuberculosis
Stephan Harbarth Switzerland, Geneva
Antibiotic treatment decisions: usefulness of biomarkers
Monica Junie Romania, Cluj-Napoca
The antibiotic resistance and their impact in the nosocomial infections
Serafim Kastanakis Greece, Chania (Crete)
Insects and Infections
Peter Kern Germany, Ulm
The Comprehensive Infectious Diseases Center Ulm: Three years experiences with infectious diseases boards as an interdisciplinary platform for treatment recommendations

Emma Keuleyan Bulgaria, Sofia
Antibiotic stewardship - theory and practices

Pavel Khaykin Germany, Frankfurt am Main
New trends in antiretroviral therapy
Vladimir Krcmery Slovakia, Bratislava
Infections during catastrophes
Cornelia Lass-Flörl Austria, Innsbruck
Emerging Fungal Infections
Arno Lechner Austria, Salzburg
New perspectives in Antimicrobial Stewardship
Antonio Melico-Silvestre Portugal, Coimbra
HIV and Viral Infections
George-Michael Petrikkos Greece, Athens
Fungal infections in ICU: Patient at risk- Epidemiology
Elisabeth Presterl Austria, Vienna
Prevention & prophylaxis of invasive fungal infections
Alexander Pretsch Austria,Tulln
SeaLife Pharma – a marine biotechnology company with a new approach to discovery novel marine anti-infective compounds
Peter Proksch Germany, Düsseldorf
New Drugs from Marine Organisms
Ralf Reinert Italy, Siena
Clinical development of new bacterial vaccines – an overview
Ferenc Rozgonyi Hungary, Budapest
Incidence and antibiotic resistance of most common sexually transmittable bacterial pathogens
Brigitte Schmied Austria, Vienna
HIV - Update
Cornelia Speth Austria, Innsbruck
Innate immunity and fungal infections
Thomas Staudinger Austria, Vienna
Can we prevent ventilator associated pneumonia?
Paul E. Verweij The Netherlands, Nijmegen
Challenges for the early diagnosis of invasive fungal infections
Tobias Welte Germany, Hannover
Community Acquired Pneumonia - Early Risk assessment leads to adaequate therapy
Birgit Willinger Austria, Vienna
Epidemiology of (invasive) fungal infections
 
 Print this pagetop
 
Topics & Lectures
European Society of Chemotherapy Infectious Diseases
    
 14th Scientific Meeting
of the European Society of Chemotherapy/
Infectious Diseases
December 8 th-11th, 2010
European Society of Chemotherapy Infectious Diseases  
 
www.escid.org/2010